FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro

Transplant Proc. 1992 Feb;24(1):321-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cyclosporine / pharmacology*
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis*
  • Dose-Response Relationship, Drug
  • Enterotoxins / pharmacology*
  • Fluorescent Antibody Technique
  • Humans
  • Interferon-gamma / biosynthesis
  • Interleukin-2 / biosynthesis
  • Interleukin-4 / biosynthesis
  • Interleukin-5 / biosynthesis
  • Ionomycin / pharmacology*
  • Kinetics
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Lymphokines / antagonists & inhibitors
  • Lymphokines / biosynthesis*
  • Lymphotoxin-alpha / biosynthesis
  • Staphylococcus aureus
  • Tacrolimus / pharmacology*
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Cytokines
  • Enterotoxins
  • Interleukin-2
  • Interleukin-5
  • Lymphokines
  • Lymphotoxin-alpha
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • enterotoxin A, Staphylococcal
  • Ionomycin
  • Interferon-gamma
  • Cyclosporine
  • Tetradecanoylphorbol Acetate
  • Tacrolimus